Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Porst

Showing results (81-90 of 109) with videos related to

Pageof 11
Sort By:
Fundamental & Clinical Pharmacology|January 1, 1989
Noradrenaline release in human corpus cavernosum and its modulation via presynaptic alpha 2-adrenoceptorsG J Molderings, M Göthert, H Van Ahlen, et al.
International Journal of Impotence Research|January 13, 1999
Intracavernous Alprostadil Alfadex--an effective and well tolerated treatment for erectile dysfunction. Results of a long-term European studyH Porst, J Buvat, E Meuleman, et al.
Der Urologe. Ausg. A|July 6, 2006
[Erectile dysfunction]G Ludwig, H Porst, U Wetterauer, et al.
Zeitschrift Fur Die Gesamte Innere Medizin Und Ihre Grenzgebiete|March 15, 1979
[Demonstration of hepatitis A virus in the feces]F Renger, C Kemmer, L Tschöpel, et al.
Zeitschrift Fur Urologie Und Nephrologie|March 1, 1988
[Ectopic ureterocele--diagnosis and therapy]H van Ahlen, P Brühl, A Bockisch, et al.
Aktuelle Traumatologie|October 1, 1987
[Etiology and therapeutic possibilities of post-traumatic erectile impotence]H Porst, H van Ahlen, W Tackmann, et al.
International Journal of Clinical Practice|May 1, 2004
Sustained efficacy and tolerability with vardenafil over 2 years of treatment in men with erectile dysfunctionC Stief, H Porst, I Sáenz De Tejada, et al.
Ceskoslovenska Gastroenterologie a Vyziva|January 1, 1982
[The epidemiology, clinical aspects, immunology and morphology of non-A, non-B hepatitis]F Renger, H Porst, K H Frank, et al.
Zeitschrift Fur Arztliche Fortbildung|October 1, 1981
[Results of epidemiologic, immunologic and morphologic studies and clinical aspects of non-A, non-B hepatitis]F Renger, H Porst, K H Frank, et al.
Vutreshni Bolesti|January 1, 1981
[Epidemiology, clinical aspects, immunology and morphology of non-A, non-B hepatitis]F Renger, H Porst, K H Frank, et al.
Pageof 11

Showing results (81-90 of 109) with videos related to

Sort By:
Pageof 11
Fundamental & Clinical Pharmacology|January 1, 1989
Noradrenaline release in human corpus cavernosum and its modulation via presynaptic alpha 2-adrenoceptorsG J Molderings, M Göthert, H Van Ahlen, et al.
International Journal of Impotence Research|January 13, 1999
Intracavernous Alprostadil Alfadex--an effective and well tolerated treatment for erectile dysfunction. Results of a long-term European studyH Porst, J Buvat, E Meuleman, et al.
Der Urologe. Ausg. A|July 6, 2006
[Erectile dysfunction]G Ludwig, H Porst, U Wetterauer, et al.
Zeitschrift Fur Die Gesamte Innere Medizin Und Ihre Grenzgebiete|March 15, 1979
[Demonstration of hepatitis A virus in the feces]F Renger, C Kemmer, L Tschöpel, et al.
Zeitschrift Fur Urologie Und Nephrologie|March 1, 1988
[Ectopic ureterocele--diagnosis and therapy]H van Ahlen, P Brühl, A Bockisch, et al.
Aktuelle Traumatologie|October 1, 1987
[Etiology and therapeutic possibilities of post-traumatic erectile impotence]H Porst, H van Ahlen, W Tackmann, et al.
International Journal of Clinical Practice|May 1, 2004
Sustained efficacy and tolerability with vardenafil over 2 years of treatment in men with erectile dysfunctionC Stief, H Porst, I Sáenz De Tejada, et al.
Ceskoslovenska Gastroenterologie a Vyziva|January 1, 1982
[The epidemiology, clinical aspects, immunology and morphology of non-A, non-B hepatitis]F Renger, H Porst, K H Frank, et al.
Zeitschrift Fur Arztliche Fortbildung|October 1, 1981
[Results of epidemiologic, immunologic and morphologic studies and clinical aspects of non-A, non-B hepatitis]F Renger, H Porst, K H Frank, et al.
Vutreshni Bolesti|January 1, 1981
[Epidemiology, clinical aspects, immunology and morphology of non-A, non-B hepatitis]F Renger, H Porst, K H Frank, et al.
Pageof 11